Stryker (NYSE:SYK) Director Ronda Stryker Sells 300,000 Shares

Stryker Corporation (NYSE:SYK) Director Ronda Stryker sold 300,000 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $335.90, for a total transaction of $100,770,000.00. Following the completion of the transaction, the director directly owned 2,301,375 shares in the company, valued at $773,031,862.50. This represents a 11.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.

Stryker Price Performance

NYSE:SYK traded down $12.01 during trading hours on Thursday, hitting $327.97. 2,232,012 shares of the stock were exchanged, compared to its average volume of 2,368,609. The firm’s fifty day moving average price is $326.19 and its 200 day moving average price is $332.95. Stryker Corporation has a 52-week low of $281.00 and a 52-week high of $396.86. The company has a market cap of $125.80 billion, a P/E ratio of 33.99, a P/E/G ratio of 2.11 and a beta of 0.76. The company has a current ratio of 2.16, a quick ratio of 1.33 and a debt-to-equity ratio of 0.59.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The firm had revenue of $6.59 billion for the quarter, compared to analyst estimates of $6.58 billion. During the same period in the previous year, the company posted $3.13 earnings per share. The business’s revenue was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, equities research analysts anticipate that Stryker Corporation will post 15.02 EPS for the current fiscal year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker’s dividend payout ratio (DPR) is 36.48%.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Gables Capital Management Inc. purchased a new stake in shares of Stryker in the 2nd quarter valued at approximately $25,000. Kilter Group LLC acquired a new stake in Stryker in the 2nd quarter valued at approximately $25,000. Godfrey Financial Associates Inc. purchased a new stake in Stryker in the fourth quarter valued at approximately $26,000. Sankala Group LLC acquired a new position in Stryker during the fourth quarter worth $26,000. Finally, Compass Financial Management LLC acquired a new position in Stryker during the second quarter worth $27,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently commented on SYK shares. Wall Street Zen upgraded Stryker from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Evercore set a $350.00 target price on Stryker in a research note on Monday, July 6th. Royal Bank Of Canada reduced their price target on Stryker from $435.00 to $420.00 and set an “outperform” rating on the stock in a report on Friday, July 31st. Weiss Ratings reissued a “hold (c)” rating on shares of Stryker in a research report on Friday, July 31st. Finally, UBS Group began coverage on shares of Stryker in a report on Tuesday, July 28th. They issued a “buy” rating and a $400.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $386.28.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.